Report date: Apr 23, 2024
Conflict count: 350216
Publisher: Elsevier 
Title count: 938
Conflict count: 15199


==========================================================

Created: 2011-11-18 08:14:47.0
ConfID: 4508099
CauseID: 1346537171
OtherID: 1364332188
JT: The Lancet Oncology
MD: null, 12 ,12,1096,2011,Errata
DOI: 10.1016/S1470-2045(11)70310-2(Journal) (4508099-N )
DOI: 10.1016/S1470-2045(11)70311-4(Journal)
==========================================================

Created: 2014-02-22 06:01:21.0
ConfID: 4516086
CauseID: 1364338668
OtherID: 1364338673
JT: The Lancet Oncology
MD: null, 6 ,6,357,2005,Errata
DOI: 10.1016/S1470-2045(05)70183-2(Journal) (4516086-N )
DOI: 10.1016/S1470-2045(05)70184-4(Journal)
==========================================================

Created: 2011-04-07 15:39:19.0
ConfID: 4528953
CauseID: 1339575452
OtherID: 1364335653
JT: The Lancet Oncology
MD: null, 11 ,3,226,2010,Errata
DOI: 10.1016/S1470-2045(10)70047-4(Journal) (4528953-N )
DOI: 10.1016/S1470-2045(10)70048-6(Journal)
==========================================================

Created: 2014-02-22 01:33:07.0
ConfID: 4536275
CauseID: 1364332945
OtherID: 1364332955
JT: The Lancet Oncology
MD: null, 9 ,9,822,2008,Errata
DOI: 10.1016/S1470-2045(08)70221-3(Journal) (4536275-N )
DOI: 10.1016/S1470-2045(08)70223-7(Journal)
==========================================================

Created: 2014-02-22 03:46:57.0
ConfID: 4545413
CauseID: 1364335707
OtherID: 175208628
JT: The Lancet Oncology
MD: Senior, 6 ,1,7,2005,Growth-factor inhibition as therapy for Kaposi''s sarcoma
DOI: 10.1016/S1470-2045(04)01699-7(Journal) (4545413-N )
DOI: 10.1016/S1470-2045(05)70012-7(Journal)
==========================================================

Created: 2011-03-04 15:41:38.0
ConfID: 4545414
CauseID: 1339004336
OtherID: 1364335692, 175208628
JT: The Lancet Oncology
MD: null, 6 ,1,10,2005,News in brief
DOI: 10.1016/S1470-2045(04)01704-8(Journal) (4545414-N )
DOI: 10.1016/S1470-2045(05)70017-6(Journal)
==========================================================

Created: 2011-04-07 15:39:12.0
ConfID: 4545530
CauseID: 1339575374
OtherID: 1364335713, 175208628
JT: The Lancet Oncology
MD: Orellana, 6 ,1,6,2005,Targeted chemotherapy against nasopharyngeal cancer
DOI: 10.1016/S1470-2045(04)01697-3(Journal) (4545530-N )
DOI: 10.1016/S1470-2045(05)70010-3(Journal)
==========================================================

Created: 2014-02-22 02:46:12.0
ConfID: 4551786
CauseID: 1364334669
JT: The Lancet Oncology
MD: null, 12 ,6,522,2011,Errata
DOI: 10.1016/S1470-2045(11)70127-9(Journal) (4551786-N )
DOI: 10.1016/S1470-2045(11)70135-8(Journal)
==========================================================

Created: 2009-04-03 04:31:22.0
ConfID: 4558821
CauseID: 767121868
OtherID: 1364324467, 1364324425
JT: The Lancet Oncology
MD: null, 7 ,2,105,2006,Errata
DOI: 10.1016/S1470-2045(06)70552-6(Journal) (4558821-N )
DOI: 10.1016/S1470-2045(06)70555-1(Journal)
==========================================================

Created: 2014-02-22 03:46:57.0
ConfID: 4560646
CauseID: 1364335710
OtherID: 175208628
JT: The Lancet Oncology
MD: Bafounta, 6 ,1,3,2005,Routine ultrasonography in melanoma follow-up?
DOI: 10.1016/S1470-2045(04)01692-4(Journal) (4560646-N )
DOI: 10.1016/S1470-2045(05)70005-X(Journal)
==========================================================

Created: 2011-03-04 15:41:38.0
ConfID: 4560647
CauseID: 1339004336
OtherID: 1364335707, 175208628
JT: The Lancet Oncology
MD: Cesario, 6 ,1,64,2005,Symptom-free T4 lung cancer with bilateral pulmonary artery infiltration
DOI: 10.1016/S1470-2045(04)01716-4(Journal) (4560647-N )
DOI: 10.1016/S1470-2045(05)70029-2(Journal)
==========================================================

Created: 2014-02-22 01:16:00.0
ConfID: 4561112
CauseID: 1364332107
OtherID: 1364332105
JT: The Lancet Oncology
MD: null, 11 ,1,14,2010,Errata
DOI: 10.1016/S1470-2045(09)70393-6(Journal) (4561112-N )
DOI: 10.1016/S1470-2045(09)70394-8(Journal)
==========================================================

Created: 2011-07-29 23:45:40.0
ConfID: 4567534
CauseID: 1341441645
OtherID: 1364324990, 1364324998
JT: The Lancet Oncology
MD: null, 12 ,8,722,2011,Errata
DOI: 10.1016/S1470-2045(11)70205-4(Journal) (4567534-N )
DOI: 10.1016/S1470-2045(11)70206-6(Journal)
==========================================================

Created: 2014-02-22 03:46:57.0
ConfID: 4567535
CauseID: 1364335707
OtherID: 175208628
JT: The Lancet Oncology
MD: Nelson, 6 ,1,7,2005,Receptor expression associated with race in prostate cancer
DOI: 10.1016/S1470-2045(04)01698-5(Journal) (4567535-N )
DOI: 10.1016/S1470-2045(05)70011-5(Journal)
==========================================================

Created: 2011-04-07 15:39:26.0
ConfID: 4574678
CauseID: 1339575512
OtherID: 1364338896
JT: The Lancet Oncology
MD: null, 9 ,7,613,2008,Errata
DOI: 10.1016/S1470-2045(08)70165-7(Journal) (4574678-N )
DOI: 10.1016/S1470-2045(08)70166-9(Journal)
==========================================================

Created: 2012-09-24 14:31:13.0
ConfID: 4574679
CauseID: 1352973119
OtherID: 1364324906, 1364324903
JT: The Lancet Oncology
MD: null, 11 ,6,516,2010,Errata
DOI: 10.1016/S1470-2045(10)70134-0(Journal) (4574679-N )
DOI: 10.1016/S1470-2045(10)70136-4(Journal)
==========================================================

Created: 2014-02-22 03:46:57.0
ConfID: 4580549
CauseID: 1364335708
OtherID: 1364335705
JT: The Lancet Oncology
MD: null, 12 ,1,11,2011,Errata
DOI: 10.1016/S1470-2045(10)70299-0(Journal) (4580549-N )
DOI: 10.1016/S1470-2045(10)70300-4(Journal)
==========================================================

Created: 2014-02-22 01:33:12.0
ConfID: 4580963
CauseID: 1364332962
OtherID: 1364332956
JT: The Lancet Oncology
MD: null, 13 ,5,186,2012,Errata
DOI: 10.1016/S1470-2045(12)70195-X(Journal) (4580963-N )
DOI: 10.1016/S1470-2045(12)70194-8(Journal)
==========================================================

Created: 2014-02-22 03:46:57.0
ConfID: 4581288
CauseID: 1364335709
OtherID: 175208628
JT: The Lancet Oncology
MD: null, 6 ,1,4,2005,Errata
DOI: 10.1016/S1470-2045(04)01694-8(Journal) (4581288-N )
DOI: 10.1016/S1470-2045(05)70007-3(Journal)
==========================================================

Created: 2014-02-21 17:47:04.0
ConfID: 4581837
CauseID: 1364323531
OtherID: 1364323534
JT: The Lancet Oncology
MD: null, 7 ,7,533,2006,Errata
DOI: 10.1016/S1470-2045(06)70738-0(Journal) (4581837-N )
DOI: 10.1016/S1470-2045(06)70740-9(Journal)
==========================================================

Created: 2009-04-03 04:31:28.0
ConfID: 4581940
CauseID: 767121919
OtherID: 1364336317, 1364336310
JT: The Lancet Oncology
MD: null, 8 ,9,761,2007,Errata
DOI: 10.1016/S1470-2045(07)70256-5(Journal) (4581940-N )
DOI: 10.1016/S1470-2045(07)70257-7(Journal)
==========================================================

Created: 2011-04-07 15:39:19.0
ConfID: 4588467
CauseID: 1339575447
OtherID: 1364336695
JT: The Lancet Oncology
MD: null, 7 ,10,797,2006,Errata
DOI: 10.1016/S1470-2045(06)70879-8(Journal) (4588467-N )
DOI: 10.1016/S1470-2045(06)70881-6(Journal)
==========================================================

Created: 2011-04-07 15:39:24.0
ConfID: 4588468
CauseID: 1339575495
OtherID: 1364335876
JT: The Lancet Oncology
MD: null, 6 ,11,826,2005,Errata
DOI: 10.1016/S1470-2045(05)70403-4(Journal) (4588468-N )
DOI: 10.1016/S1470-2045(05)70404-6(Journal)
==========================================================

Created: 2009-04-03 04:31:22.0
ConfID: 4588474
CauseID: 767121868
OtherID: 1364323506
JT: The Lancet Oncology
MD: null, 7 ,3,194,2006,Errata
DOI: 10.1016/S1470-2045(06)70591-5(Journal) (4588474-N )
DOI: 10.1016/S1470-2045(06)70592-7(Journal)
==========================================================

Created: 2014-02-22 03:46:57.0
ConfID: 4593805
CauseID: 1364335706
OtherID: 175208628
JT: The Lancet Oncology
MD: Machet, 6 ,1,2,2005,Routine ultrasonography in melanoma follow-up?
DOI: 10.1016/S1470-2045(04)01691-2(Journal) (4593805-N )
DOI: 10.1016/S1470-2045(05)70004-8(Journal)
==========================================================

Created: 2014-02-22 06:01:10.0
ConfID: 4601850
CauseID: 1364338636
OtherID: 1364338641
JT: The Lancet Oncology
MD: null, 8 ,8,670,2007,Errata
DOI: 10.1016/S1470-2045(07)70218-8(Journal) (4601850-N )
DOI: 10.1016/S1470-2045(07)70221-8(Journal)
==========================================================

Created: 2014-02-22 03:46:52.0
ConfID: 4601952
CauseID: 1364335701
OtherID: 175208628
JT: The Lancet Oncology
MD: Bradbury, 6 ,1,8,2005,CORE breast-cancer prevention trial
DOI: 10.1016/S1470-2045(04)01700-0(Journal) (4601952-N )
DOI: 10.1016/S1470-2045(05)70013-9(Journal)
==========================================================

Created: 2011-03-04 15:41:38.0
ConfID: 4614731
CauseID: 1339004336
OtherID: 1364335711, 175208628
JT: The Lancet Oncology
MD: Davis, 6 ,1,14,2005,Assessment of pain
DOI: 10.1016/S1470-2045(04)01708-5(Journal) (4614731-N )
DOI: 10.1016/S1470-2045(05)70021-8(Journal)
==========================================================

Created: 2011-04-07 15:39:14.0
ConfID: 4638970
CauseID: 1339575400
OtherID: 1364335698, 175208628
JT: The Lancet Oncology
MD: Bagchi, 6 ,1,9,2005,One Pap smear of benefit in developing countries
DOI: 10.1016/S1470-2045(04)01703-6(Journal) (4638970-N )
DOI: 10.1016/S1470-2045(05)70016-4(Journal)
==========================================================

Created: 2014-02-22 03:46:52.0
ConfID: 4643686
CauseID: 1364335702
OtherID: 175208628
JT: The Lancet Oncology
MD: McCaffrey, 6 ,1,5,2005,Bank on it: umbilical-cord blood for transplantation
DOI: 10.1016/S1470-2045(04)01695-X(Journal) (4643686-N )
DOI: 10.1016/S1470-2045(05)70008-5(Journal)
==========================================================

Created: 2014-02-22 03:46:52.0
ConfID: 4650700
CauseID: 1364335701
OtherID: 175208628
JT: The Lancet Oncology
MD: Ahmad, 6 ,1,9,2005,Small subsets of cells initiate brain tumours
DOI: 10.1016/S1470-2045(04)01702-4(Journal) (4650700-N )
DOI: 10.1016/S1470-2045(05)70015-2(Journal)
==========================================================

Created: 2009-04-03 04:31:28.0
ConfID: 4671430
CauseID: 767121919
OtherID: 1364336194
JT: The Lancet Oncology
MD: null, 8 ,3,191,2007,Errata
DOI: 10.1016/S1470-2045(07)70055-4(Journal) (4671430-N )
DOI: 10.1016/S1470-2045(07)70056-6(Journal)
==========================================================

Created: 2011-04-07 15:39:12.0
ConfID: 4672938
CauseID: 1339575374
OtherID: 1364335706, 175208628
JT: The Lancet Oncology
MD: Owen, 6 ,1,6,2005,Trials investigate first-line thalidomide in multiple myeloma
DOI: 10.1016/S1470-2045(04)01696-1(Journal) (4672938-N )
DOI: 10.1016/S1470-2045(05)70009-7(Journal)
==========================================================

Created: 2009-04-03 04:31:28.0
ConfID: 4683440
CauseID: 767121919
OtherID: 1364325675
JT: The Lancet Oncology
MD: null, 9 ,10,919,2008,Errata
DOI: 10.1016/S1470-2045(08)70245-6(Journal) (4683440-N )
DOI: 10.1016/S1470-2045(08)70246-8(Journal)
==========================================================

Created: 2014-02-22 03:46:52.0
ConfID: 4699419
CauseID: 1364335701
OtherID: 175208628
JT: The Lancet Oncology
MD: Bosch, 6 ,1,8,2005,Bone-marrow-derived cells implicated in gastric cancer
DOI: 10.1016/S1470-2045(04)01701-2(Journal) (4699419-N )
DOI: 10.1016/S1470-2045(05)70014-0(Journal)
==========================================================

Created: 2011-04-07 15:39:12.0
ConfID: 4723541
CauseID: 1339575378
OtherID: 1364331849
JT: The Lancet Oncology
MD: null, 10 ,12,1142,2009,Errata
DOI: 10.1016/S1470-2045(09)70356-0(Journal) (4723541-N )
DOI: 10.1016/S1470-2045(09)70357-2(Journal)